Background Excessive sleepiness (ES) is a common symptom of OSA, which often persists
despite primary OSA therapy. This phase III randomized withdrawal trial evaluated …

Excessive daytime sleepiness (EDS) and neurocognitive dysfunction are commonly
observed in patients with obstructive sleep apnea (OSA), and these daytime functional …

Excessive daytime sleepiness (EDS) is a major symptom of obstructive sleep apnoea (OSA),
defined as the inability to stay awake during the day. Its clinical descriptors remain elusive …

Obstructive sleep apnea (OSA) has been historically described as a disease primarily of
men. However, it is now widely recognized that OSA in women is not as rare as was …

Background Continuous positive airway pressure (CPAP) is typically recommended as first
line therapy for obstructive sleep apnea, but the adherence rate of CPAP is problematic. This …

Obstructive sleep apnea (OSA) is a sleep-related breathing disorder characterized by
repetitive episodes of airflow cessation resulting in brief arousals and intermittent …

Obstructive sleep apnea (OSA) is a disorder characterized by repeated episodes of
complete (apneas) or partial (hypopneas) cessations of breathing while sleeping. While …

Rationale: Clear definition of optimal positive airway pressure therapy usage in patients with
obstructive sleep apnea is not possible because of scarce data on the relationship between …

Abstract Study Objectives To evaluate long-term safety and maintenance of efficacy of
solriamfetol treatment for excessive daytime sleepiness in narcolepsy and obstructive sleep …

Objective: This scoping review aims to provide an accessible summary of available
evidence on the efficacy of motivational interventions to increase adherence to Continuous …